Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension trials: 1990 to 2000.

N M Kaplan1

  • 1Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, 75390-8899, USA.

Current Opinion in Nephrology and Hypertension
|July 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editor's Mail.

Postgraduate medicine·2016
Same author

Microbiology of wound infection after caesarean section in a Jordanian hospital.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2006
Same author

What is the impact of systolic blood pressure lowering on preventing cardiovascular events?

Journal of human hypertension·2004
Same author

The place of diuretics in preventing cardiovascular events.

Journal of human hypertension·2004
Same author

Use of thermonuclease testing to identify Staphylococcus aureus by direct examination of blood cultures.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2004
Same author

Executive summaries on hypertension II. Choices of initial drug therapy.

Drugs of today (Barcelona, Spain : 1998)·2004

For most patients with hypertension, individualized therapy is recommended, as no single drug is superior. For diabetic hypertensive patients, angiotensin-converting enzyme inhibitors are typically the preferred initial choice.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Randomized controlled trials (RCTs) over the past decade have evaluated hypertension therapies.
  • Early RCTs confirmed benefits of low-dose diuretic-based therapy.
  • Recent RCTs demonstrate comparable effectiveness of angiotensin-converting enzyme inhibitors (ACEIs) and calcium antagonists (CCBs).

Purpose of the Study:

  • To review comparative data on hypertension drug effectiveness.
  • To provide guidance on individualized drug selection for hypertensive patients.
  • To address treatment strategies for diabetic hypertensive patients.

Main Methods:

  • Systematic review of published randomized controlled trials.
  • Analysis of comparative effectiveness data for different antihypertensive drug classes.

Related Experiment Videos

  • Evaluation of treatment outcomes based on patient comorbidities.

    • Main Results:

    • No single antihypertensive drug class demonstrates clear superiority for most patients.
    • Individualized treatment selection based on concomitant conditions is recommended.
    • For diabetic hypertensive patients, ACEIs are generally the preferred initial choice, often requiring combination therapy with diuretics and CCBs for adequate control.

    Conclusions:

    • Initial antihypertensive drug choice should be individualized.
    • ACEIs are a recommended initial therapy for diabetic hypertensive patients.
    • CCBs can be safely used in diabetic hypertensive patients.